T. Rowe Price TROW · NASDAQ
$103.99 -1.11% (-$1.17)
Summary
87 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 29 USD is left as net profit.
- You pay 10.1 USD for 1 USD of yearly profit, little for its sector.
- Earnings per share grew by 11% a year over the last 3 years.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Asset Management)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.1 USD for 1 USD of yearly profit. Over the last five years it was 13.4 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 3.3% a year over 5 years. Over the last 3 years it grew by 4.1% a year. For the next fiscal year analysts expect revenue to grow by 5.9%. Earnings per share grew by 11% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 29 USD
- Sales and administration 40 USD
- Taxes and other 1.0 USD
- Net profit 29 USD
Net profit, industry median (Asset Management) 24 USD
Out of every 100 USD of revenue, 29 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 4.92%
- Paid out of profit
- 50%
- Raised in a row
- 3 years
You receive $5.17 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 8
- Hold 24
- Sell 6
Today's price within the analysts' price targets
The average target of $112 is 7.7% above today's price. 21% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Asset Management 99%
- Capital Allocation Based Income 1.2%
By region
The company reports no revenue by region.
Asset Management brings in 99% of revenue.
Segments in detail